Skip to main content
. 2020 Oct 13;15(5):450–469. doi: 10.1159/000511788

Table 5.

Anti-HER2 targeted antibody trials for breast cancer in the recruitment phase

Agent Trial / Phase Setting
Margetuximab A Study to Evaluate the Efficacy and Safety of Margetuximab plus Chemotherapy in the Treatment of Chinese Patients with HER2+ MBC / Phase 2 Metastatic

A Study of MGD013 in Patients with Unresectable or Metastatic Neoplasms / Phase 1 Metastatic